In 1989, at the age of 30, José moved to MSK to work in the clinic with Larry Norton and in the laboratory with John Mendelsohn to investigate the anti-tumor activity of therapies that block the epidermal growth factor receptor (EGFR) and HER2 on cancer cell lines. This evidence concerns the gene EGFR and cancer.